MedTrace Logo

The Effect of Vicia Faba Hydrolysate Supplementation on Muscle Strength Recovery

NCT06837298 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2025-02-20

No results posted yet for this study

Summary

To investigate the effect of Vicia faba protein concentrate, a protein derived from Fava bean extract, on delayed onset muscle soreness (DOMS). Participants receive either 2.4g/day of PeptiStrong® supplement capsules or placebo capsules for 14 days until a strenuous exercise session. For the last 3 days, 2/3 of them stay on the same treatment and 1/3 of them switch from placebo to PeptiStrong®.

Conditions

  • Muscle Damage
  • Muscle

Interventions

OTHER

Placebo control capsules

2.4 grams (g) daily

OTHER

PeptiStrong® supplement capsules with same appearance as placebo capsules

2.4 g daily

OTHER

PeptiStrong® supplement capsules following muscle damaging exercise on Day 14

2.4 g placebo capsules for 14 days, then 3 days 2.4 g of PeptiStrong® capsules following one muscle damaging exercise session

Sponsors & Collaborators

  • PepsiCo Global R&D

    lead INDUSTRY

Principal Investigators

  • Kris Osterberg, PhD, RD · PepsiCo R&D Life Sciences, Sports Science

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-07
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06837298 on ClinicalTrials.gov